The researchers say their findings constitute a significant step forward in understanding the interaction between the mind and the skeletal system. Based on their findings, the researchers have already been able to demonstrate the efficacy of anti-depressant drugs in preventing bone mass loss.
The findings of the Hebrew University researchers are being published this week in the American journal PNAS (Proceedings of the National Academy of Sciences).
Participants in the project were researchers from the university’s Brain and Behavior Laboratory, headed by Prof. Raz Yirmia; from the Bone Laboratory, headed by Prof. Itai Bab; and from the Brain Trauma Laboratory, headed by Prof. Esther Shohami. Also participating were doctoral students Inbal Goshen, Alon Bajayo , Tirza Kreisel, Sharon Feldman and Yosef Tam
Loss of bone mass is the leading cause of osteoporosis and bone fractures among the aged in general and among post-menopausal women in particular. Several studies indicate that people with major depression generally have a lower bone mass density compared to control samples; however, no direct link between these two conditions has been established.
In order to examine the connection between depression and bone mass loss, the researchers used a model involving laboratory mice. Following the induction of a depression-like condition, the mice developed behavioral symptoms mirroring those seen in depressed humans, including a reduction in pleasurable activity and in social interaction.
After four weeks in a depressed state, the laboratory animals showed a dramatic bone mass loss, including in the hip bone and vertebrae. This loss was caused by impairment in the bone renewal process, which is essential to maintaining normal bone density. This impairment was caused by a reduction in the number of bone-building cells, which are called osteoblasts.
The laboratory tests showed that chronic use of an anti-depressant drug halted not only the depression itself but also the loss of bone density.
The researchers were also able to describe the process connecting depression to the skeletal structure. They found that depression sets off a neural system connecting the brain to the internal organs, including the skeleton. This system is called the “sympathetic nervous system.” Its activation causes the secretion within the bone of a chemical compound called noradrenaline, which has a detrimental effect on the bone-building cells. The researchers were able to show that chronic treatment with a drug that blocks noradrenaline in the bone also blocks the detrimental influence of depression on the bone.
This research serves as the basis for new, efficient drugs for treatment of osteoporosis, which is the most prevalent degenerative disease in western society. The Hebrew University’s technology transfer company, Yissum, has applied for a patent for treatment of osteoporosis through anti-depressants.
“The connection between the brain and the skeleton in general, and the influence of depression on bone mass in particular is a new area of research about which we still know very little,” said Prof. Yirmiya. “The new findings, which we have discovered in the Hebrew University laboratories, point for the first time to depression as an important element in causing bone mass loss and osteoporosis.”
Prof. Bab said that “together with other research which we have published in the past year, we have developed a new area of research that we call ‘neuro-psycho-osteology,’ which deals with the connection between the brain, mental states and the skeleton.”
The research at the Hebrew University was carried out with funding from the Bikura program of the Israel National Science Foundation.
Jerry Barach | alfa
Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg
New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences